SCHEMBL7653650

SCHEMBL7653650

O=C(NC(CO)CO)c1cncc(C(=O)NC(CO)CO)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.45
CASP3 P42574 3/20 0.45
ALDH1A1 P00352 2/20 0.45
HSD17B10 Q99714 1/20 0.45
HPGD P15428 1/20 0.44
ROCK2 O75116 2/20 0.42
PRKACA P17612 2/20 0.42
MAPK1 P28482 2/20 0.42
IRAK1 P51617 2/20 0.42
PRKX P51817 2/20 0.42
ROCK1 Q13464 2/20 0.42
PRKG1 Q13976 2/20 0.42
PKN2 Q16513 2/20 0.42
CLK4 Q9HAZ1 2/20 0.42
RPS6KA5 O75582 1/20 0.42
RPS6KA4 O75676 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
SGK2 Q9HBY8 1/20 0.42
XDH P47989 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7654698 0.79 KDM4E (0.44) KDM4ECASP3ALDH1A1HSD17B10HPGD
SCHEMBL13724316 0.79 THRB (0.63) ALDH1A1ROCK2ROCK1GAATP53
SCHEMBL3403490 0.78 NQO2 (0.40) KDM4EALDH1A1HSD17B10HPGDROCK2
SCHEMBL7660893 0.78 KDM4E (0.47) KDM4ECASP3ALDH1A1HSD17B10HPGD
SCHEMBL7654705 0.78 KDM4E (0.40) KDM4ECASP3ALDH1A1HSD17B10HPGD
SCHEMBL30358364 0.77 HTT (0.40) KDM4ECASP3ALDH1A1ROCK2PRKACA
SCHEMBL22815235 0.77 BACE1 (0.43) ROCK2PRKACAMAPK1IRAK1PRKX
SCHEMBL4609315 0.77 TAS1R3 (0.38) KDM4EALDH1A1ROCK2PRKACAMAPK1
SCHEMBL7108034 0.77 CNR1 (0.44) ROCK2PRKACAMAPK1IRAK1PRKX
SCHEMBL7653658 0.77 KDM4E (0.44) KDM4ECASP3ALDH1A1HSD17B10HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US claimed
EP-1001944-A1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP claimed
WO-1999003844-A1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO claimed
US-6399613-B1 N,N'-BIS(2-HYDROXYETHYL)PYRAZINE-2,5- OR -2,6-DICARBOXAMIDE; DIABETES AVENTIS PHARMA S.A. (FR) 2002-06-04 US disclosed
EP-1001944-A1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM Aventis Pharma S.A. (FR) 2000-05-24 EP disclosed
WO-1999003844-A1 PYRAZINE DERIVATIVES, PREPARATION AND MEDICINES CONTAINING THEM RHONE-POULENC RORER S.A. (FR) 1999-01-28 WO disclosed